NEWPHARMA, INC. – Trademark Portfolio

Entity Type: 03

NEWPHARMA, INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. Currently, 10 trademarks are registered. Notable registered marks include IROFOL, ALMEBEX, LIDONEX, VENATON, and FLATULEX. The owner is based in MIAMI, FL.

3307 NORTHWEST 74TH AVENUE

MIAMI, FL 33122

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LIDONEX
LIDONEX
Registered 2022
FEOSTAT
FEOSTAT
Abandoned 2021
VENATON
VENATON
Registered 2018
VENIPHLEX
VENIPHLEX
Registered 2018
FLATULEX
FLATULEX
Registered 2017
SERENITAS
SERENITAS
Registered 2013
FLATULEX
FLATULEX
Abandoned 2013
ALMEBEX
ALMEBEX
Registered 2013
MERITENE
MERITENE
Registered 2005
PROVASMIN
PROVASMIN
Registered 1996
IROFOL
IROFOL
Registered 1994

Trademark Classifications

NEWPHARMA, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (14 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does NEWPHARMA, INC. have?

NEWPHARMA, INC. has 14 U.S. trademarks filed with the USPTO. Of these, 10 registered, 2 abandoned, 2 cancelled.

What trademark classes does NEWPHARMA, INC. file in?

NEWPHARMA, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NEWPHARMA, INC.'s most well-known trademarks?

NEWPHARMA, INC.'s registered trademark portfolio includes well-known marks such as IROFOL, ALMEBEX, LIDONEX, VENATON, and FLATULEX. These are among 10 currently registered trademarks in the portfolio.

What is NEWPHARMA, INC.'s trademark registration success rate?

NEWPHARMA, INC. has a 71% trademark registration rate, with 10 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.